---
figid: PMC6719725__41592_2019_509_Fig6_HTML
figlink: /pmc/articles/PMC6719725/figure/Fig6/
number: Fig. 6
caption: a–c, The modules are from the STRING protein–protein interaction networks
  and were generated using the consensus method. Node colors correspond to Pascal
  gene scores in the respective GWAS (). For the two inflammatory disorders (a,b),
  red squares indicate genes causing monogenic immunodeficiency disorders (enrichment
  P values of 4.1 × 10−8 and 1.2 × 10−6, respectively (one-sided Fisher’s exact test)).
  a, Module associated with rheumatoid arthritis (n = 25 genes, FDR-corrected Pascal
  P = 0.04) that is involved in T cell activation. A costimulatory pathway is highlighted
  green, T cell response is regulated by activating (CD28) and inhibitory (CTLA4)
  surface receptors, which bind B7 family ligands (CD80 and CD86) expressed on the
  surface of activated antigen-presenting cells. The therapeutic agent CTLA4-Ig binds
  and blocks B7 ligands, thus inhibiting T cell response. b, Cytokine signaling module
  associated with inflammatory bowel disease (n = 42 genes, FDR-corrected Pascal P = 0.0006).
  The module includes the four known Janus kinases (JAK1-3 and TYK2, highlighted green),
  which are engaged by cytokine receptors to mediate activation of specific transcription
  factors (STATs). Inhibitors of JAK–STAT signaling are being tested in clinical trials
  for both ulcerative colitis and Crohn’s disease. c, Module associated with myocardial
  infarction (n = 36 genes, FDR-corrected Pascal P = 0.0001) comprising two main components
  of the NO/cGMP signaling pathway (endothelial nitric oxide synthases (NOS1-3) and
  soluble guanylate cyclases (GUCY1A2, GUCY1A3 and GUCY1B3), highlighted green), a
  key therapeutic target for cardiovascular disease.
pmcid: PMC6719725
papertitle: Assessment of network module identification across complex diseases.
reftext: Sarvenaz Choobdar, et al. Nat Methods. 2019 Sep;16(9):843-852.
pmc_ranked_result_index: '68103'
pathway_score: 0.6669896
filename: 41592_2019_509_Fig6_HTML.jpg
figtitle: Assessment of network module identification across complex diseases
year: '2019'
organisms: Homo sapiens
ndex: bedcfc9a-df2c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6719725__41592_2019_509_Fig6_HTML.html
  '@type': Dataset
  description: a–c, The modules are from the STRING protein–protein interaction networks
    and were generated using the consensus method. Node colors correspond to Pascal
    gene scores in the respective GWAS (). For the two inflammatory disorders (a,b),
    red squares indicate genes causing monogenic immunodeficiency disorders (enrichment
    P values of 4.1 × 10−8 and 1.2 × 10−6, respectively (one-sided Fisher’s exact
    test)). a, Module associated with rheumatoid arthritis (n = 25 genes, FDR-corrected
    Pascal P = 0.04) that is involved in T cell activation. A costimulatory pathway
    is highlighted green, T cell response is regulated by activating (CD28) and inhibitory
    (CTLA4) surface receptors, which bind B7 family ligands (CD80 and CD86) expressed
    on the surface of activated antigen-presenting cells. The therapeutic agent CTLA4-Ig
    binds and blocks B7 ligands, thus inhibiting T cell response. b, Cytokine signaling
    module associated with inflammatory bowel disease (n = 42 genes, FDR-corrected
    Pascal P = 0.0006). The module includes the four known Janus kinases (JAK1-3 and
    TYK2, highlighted green), which are engaged by cytokine receptors to mediate activation
    of specific transcription factors (STATs). Inhibitors of JAK–STAT signaling are
    being tested in clinical trials for both ulcerative colitis and Crohn’s disease.
    c, Module associated with myocardial infarction (n = 36 genes, FDR-corrected Pascal
    P = 0.0001) comprising two main components of the NO/cGMP signaling pathway (endothelial
    nitric oxide synthases (NOS1-3) and soluble guanylate cyclases (GUCY1A2, GUCY1A3
    and GUCY1B3), highlighted green), a key therapeutic target for cardiovascular
    disease.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HTRA4
  - RPL18
  - BRS3
  - CBLB
  - CD4
  - CTLA4
  - EOMES
  - FYB1
  - GRAP2
  - TYK2
  - JAK2
  - TFF3
  - PPAT
  - LAT
  - MPO
  - POR
  - REL
  - IL17F
  - JAK1
  - RETNLB
  - JAK3
  - ABRA
  - STAT4
  - RICTOR
  - SLA
  - HTRA2
  - STAP2
  - 'NO'
  - CGMP
  - O
  - bowel disease
  - Rheumatoid arthritis
  - Myocardial infarction
genes:
- word: HTRA4
  symbol: HTRA4
  source: hgnc_symbol
  hgnc_symbol: HTRA4
  entrez: '203100'
- word: L18
  symbol: L18
  source: hgnc_alias_symbol
  hgnc_symbol: RPL18
  entrez: '6141'
- word: BB3
  symbol: BB3
  source: hgnc_alias_symbol
  hgnc_symbol: BRS3
  entrez: '680'
- word: CBLB
  symbol: CBLB
  source: hgnc_symbol
  hgnc_symbol: CBLB
  entrez: '868'
- word: CD4
  symbol: CD4
  source: hgnc_symbol
  hgnc_symbol: CD4
  entrez: '920'
- word: CTLA4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: EOMES
  symbol: EOMES
  source: hgnc_symbol
  hgnc_symbol: EOMES
  entrez: '8320'
- word: FYB
  symbol: FYB
  source: hgnc_prev_symbol
  hgnc_symbol: FYB1
  entrez: '2533'
- word: GRAP2
  symbol: GRAP2
  source: hgnc_symbol
  hgnc_symbol: GRAP2
  entrez: '9402'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: TFF3
  symbol: TFF3
  source: hgnc_symbol
  hgnc_symbol: TFF3
  entrez: '7033'
- word: PRAT
  symbol: PRAT
  source: hgnc_alias_symbol
  hgnc_symbol: PPAT
  entrez: '5471'
- word: LAT
  symbol: LAT
  source: hgnc_symbol
  hgnc_symbol: LAT
  entrez: '27040'
- word: MPO
  symbol: MPO
  source: hgnc_symbol
  hgnc_symbol: MPO
  entrez: '4353'
- word: POR
  symbol: POR
  source: hgnc_symbol
  hgnc_symbol: POR
  entrez: '5447'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: REL
  symbol: REL
  source: hgnc_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: IL17F
  symbol: IL17F
  source: hgnc_symbol
  hgnc_symbol: IL17F
  entrez: '112744'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: RETNLB
  symbol: RETNLB
  source: hgnc_symbol
  hgnc_symbol: RETNLB
  entrez: '84666'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: stArS
  symbol: STARS
  source: hgnc_alias_symbol
  hgnc_symbol: ABRA
  entrez: '137735'
- word: STAT4
  symbol: STAT4
  source: hgnc_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: RICTOR
  symbol: RICTOR
  source: hgnc_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: SLA
  symbol: SLA
  source: hgnc_symbol
  hgnc_symbol: SLA
  entrez: '6503'
- word: HTRA2
  symbol: HTRA2
  source: hgnc_symbol
  hgnc_symbol: HTRA2
  entrez: '27429'
- word: STAP2
  symbol: STAP2
  source: hgnc_symbol
  hgnc_symbol: STAP2
  entrez: '55620'
chemicals:
- word: 'NO'
  source: ''
  identifier: ''
- word: CGMP
  source: MESH
  identifier: C016276
- word: O
  source: MESH
  identifier: D013481
diseases:
- word: bowel disease
  source: MESH
  identifier: D015212
- word: Rheumatoid arthritis
  source: MESH
  identifier: D001172
- word: Myocardial infarction
  source: MESH
  identifier: D009203
---
